DRKS00006219已完成不适用
Extension of the EUROBservational Research Programme Atrial Fibrillation General Registry (EORP AFIB registry) for Germany - AFNET-EORP registry Atrial Fibrillation Germany
Die Register-Studie wird durchgeführt vom: Kompetenznetz Vorhofflimmern AFNET e.V.0 个研究点目标入组 3,528 人开始时间: 2014年7月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 3,528
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients will be officially enrolled in the study only if ECG diagnosis of AF has been made.
- •- The qualifying episode of AF should have occurred within one year before the date of baseline.
- •- AF is the primary or secondary diagnosis, i.e. the current admission / visit may be due to other reasons.
- •- Patients need not be in AF at the time of enrolment.
- •- Signed Patient Inform Consent
- •- Age <= 18 years
排除标准
- •Patients who are currently or are planned to be taking part in a cardiac clinical trial.
- •Please note that patients can participate concomitantly in other registries.
研究者
相似试验
进行中（未招募）
1 期
Study to evaluate immunogenicity and safety of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine at 9 and 10 years after vaccine administration and assessment of re-vaccination with 2 additional doses at 10 years after initial vaccination, in healthy subjects aged 60 years of age and older.Herpes Zoster (HZ)MedDRA version: 18.1Level: PTClassification code 10019974Term: Herpes zosterSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 18.1Level: HLTClassification code 10019972Term: Herpes viral infectionsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 18.1Level: HLGTClassification code 10047438Term: Viral infectious disordersSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 18.1Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2015-004400-30-CZGlaxoSmithKline Biologicals SA100
进行中（未招募）
1 期
Study to evaluate immunogenicity and safety of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine at 9 and 10 years after vaccine administration and assessment of re-vaccination with 2 additional doses at 10 years after initial vaccination, in healthy subjects aged 60 years of age and older.EUCTR2015-004400-30-DEGlaxoSmithKline Biologicals100
进行中（未招募）
1 期
ong-Term Safety and Efficacy of Asfotase Alfa in Children with Hypophosphatasia (HPP)MedDRA version: 20.0Level: PTClassification code 10049933Term: HypophosphatasiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersHypophosphatasiaEUCTR2017-003153-42-Outside-EU/EEAAlexion Pharma GmbH12
尚未招募
不适用
GO OBSERVE: A European observational study in adults with moderate to severe ulcerative colitis in which the patient reports his or her response to SIMPONI at home through a website.C, ulcerative colitis, IBD, golimumab, SIMPONINL-OMON22604MSD B.V.33
已完成
不适用
An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients-G20 Parkinson´s diseaseParkinson´s diseaseG20PER-031-07SOLVAY PHARMACEUTICALS,